Shandong Realcan Pharmaceutical Co Ltd (002589) - Total Assets

Latest as of March 2026: CN¥15.55 Billion CNY ≈ $2.27 Billion USD

Based on the latest financial reports, Shandong Realcan Pharmaceutical Co Ltd (002589) holds total assets worth CN¥15.55 Billion CNY (≈ $2.27 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Shandong Realcan Pharmaceutical Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Shandong Realcan Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Shandong Realcan Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Shandong Realcan Pharmaceutical Co Ltd's total assets of CN¥15.55 Billion consist of 65.8% current assets and 34.2% non-current assets. Review 002589 total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	26.1%
Accounts Receivable	CN¥3.71 Billion	25.8%
Inventory	CN¥715.30 Million	5.0%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥528.80 Million	3.7%
Goodwill	CN¥146.67 Million	1.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shandong Realcan Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Shandong Realcan Pharmaceutical Co Ltd's current assets represent 65.8% of total assets in 2025, a decrease from 92.2% in 2008.
Cash Position: Cash and equivalents constituted 26.1% of total assets in 2025, up from 11.2% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2008.
Asset Diversification: The largest asset category is accounts receivable at 25.8% of total assets.

Shandong Realcan Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Shandong Realcan Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Brazil	R$5.64 Billion
Sigma Healthcare Ltd AU:SIG	Australia	AU$8.74 Billion
Ebos Group Ltd AU:EBO	Australia	AU$8.80 Billion
Mayne Pharma Group Ltd AU:MYX	Australia	AU$1.01 Billion
Paragon Care Ltd AU:PGC	Australia	AU$1.31 Billion
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	China	CN¥235.37 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHG:600332	China	CN¥89.76 Billion
Jointown Pharmaceutical Group Co Ltd SHG:600998	China	CN¥112.28 Billion

Shandong Realcan Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.10	1.12	1.24
Quick Ratio	1.03	1.05	1.11
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥948.80 Million	CN¥1.22 Billion	CN¥4.61 Billion

Shandong Realcan Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Shandong Realcan Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.75
Latest Market Cap to Assets Ratio	0.05
Asset Growth Rate (YoY)	-10.3%
Total Assets	CN¥14.37 Billion
Market Capitalization	$709.00 Million USD

Valuation Analysis

Below Book Valuation: The market values Shandong Realcan Pharmaceutical Co Ltd's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Shandong Realcan Pharmaceutical Co Ltd's assets decreased by 10.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual total assets of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥14.37 Billion ≈ $2.10 Billion	-10.26%
2024-12-31	CN¥16.01 Billion ≈ $2.34 Billion	-4.17%
2023-12-31	CN¥16.71 Billion ≈ $2.45 Billion	-8.85%
2022-12-31	CN¥18.33 Billion ≈ $2.68 Billion	-30.56%
2021-12-31	CN¥26.40 Billion ≈ $3.86 Billion	-15.64%
2020-12-31	CN¥31.29 Billion ≈ $4.58 Billion	-3.62%
2019-12-31	CN¥32.47 Billion ≈ $4.75 Billion	-6.81%
2018-12-31	CN¥34.84 Billion ≈ $5.10 Billion	+29.10%
2017-12-31	CN¥26.98 Billion ≈ $3.95 Billion	+72.34%
2016-12-31	CN¥15.66 Billion ≈ $2.29 Billion	+76.68%
2015-12-31	CN¥8.86 Billion ≈ $1.30 Billion	+56.06%
2014-12-31	CN¥5.68 Billion ≈ $830.92 Million	+27.48%
2013-12-31	CN¥4.45 Billion ≈ $651.79 Million	+42.75%
2012-12-31	CN¥3.12 Billion ≈ $456.61 Million	+40.71%
2011-12-31	CN¥2.22 Billion ≈ $324.50 Million	+49.89%
2010-12-31	CN¥1.48 Billion ≈ $216.49 Million	+42.26%
2009-12-31	CN¥1.04 Billion ≈ $152.18 Million	+45.34%
2008-12-31	CN¥715.53 Million ≈ $104.70 Million	--

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution

Market Cap

$709.00 Million

CN¥4.85 Billion CNY

Market Cap Rank

#10623 Global

#2888 in China

Share Price

CN¥3.22

Change (1 day)

+0.94%

52-Week Range

CN¥2.45 - CN¥4.69

All Time High

CN¥17.35